| Financial Year |
March 31 2023 |
| Monetary Funds |
992,702,702.67 |
| Held-for-trading Financial Assets |
129,584,096.66 |
| Notes Receivable |
9,022,127.00 |
| Accounts Receivable |
320,802,675.86 |
| Advances to Suppliers |
8,846,245.13 |
| Other Receivables |
71,949,979.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,690,296,042.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,037,561.34 |
| Total Current Assets |
3,319,939,503.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
23,041,000.99 |
| Long-term Equity Investment |
140,192,124.81 |
| Investment Properties |
968,142,189.77 |
| Fixed Assetes |
299,647,342.28 |
| Under-construction Projects |
8,568,692.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,822,453.72 |
| R&D expenses |
-- |
| Goodwill |
70,827,727.55 |
| Long-Term Deferred and Prepaid Expenses |
27,290,599.09 |
| Deferred Income Tax Assets |
73,610,820.63 |
| Other Non-Current Assets |
80,965,609.00 |
| Sub-Total of Non-Current Assets |
1,952,612,889.08 |
| Total Assets |
5,272,552,392.46 |
| Short-Term Loans |
210,181,111.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
464,256,350.16 |
| Accounts Received In Advance |
156,511,392.17 |
| Employee Compensation Payable |
100,535,919.01 |
| Taxes Payable |
140,749,879.18 |
| Interest Payable |
-- |
| Dividend Payable |
23,312,295.44 |
| Other payables |
802,065,258.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
105,756,599.81 |
| Other Current Liabilities |
4,554,412.54 |
| Sub-Total of Current Liabilities |
2,021,888,735.51 |
| Long-term Loans |
525,788,609.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,820,080.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
55,155,504.76 |
| Deferred Income Tax Liabilities |
9,887,349.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
764,157,545.28 |
| Total Liabilities |
2,786,046,280.79 |
| Paid-In Capital(Or Share Stock) |
1,231,200,672.00 |
| Capital Surplus |
165,950,347.39 |
| Surplus Reserve |
183,634,506.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
384,910,913.40 |
| Minority Stockholder's Interest |
523,712,142.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,962,793,968.88 |
| Owner's Equity（Stockholder's Equity） |
2,486,506,111.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,272,552,392.46 |
